<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01013233</url>
  </required_header>
  <id_info>
    <org_study_id>KTST09</org_study_id>
    <nct_id>NCT01013233</nct_id>
  </id_info>
  <brief_title>Cognitive Training to Improve Cognitive Function Following Chemotherapy</brief_title>
  <acronym>KT</acronym>
  <official_title>Training of Cognitive Function of Patients After Chemotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Freie Universität Berlin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to improve cognitive dysfunction following chemotherapy, the
      investigators investigated to see whether a cognitive training for memory and concentration
      skills can improve cognitive performance in patients following cancer treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients following chemotherapy invited for a cognitive training. Before and after cognitive
      function will evaluate.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>December 2009</start_date>
  <completion_date type="Anticipated">October 2011</completion_date>
  <primary_completion_date type="Anticipated">October 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>several cognitive tests (TAP, VLMT, TMT, Stroop, RWT, D2, LGT-3)</measure>
    <time_frame>one weeks following the end of the cognitive training</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>quality of life and subjective perception of cognitive problems</measure>
    <time_frame>7 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Cognitive Dysfunction</condition>
  <arm_group>
    <arm_group_label>training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group start the cognitive training over 6 weeks directly after randomization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>In this control group begin the training in a cross-over design 7 weeks after randomization.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>cognitive training</intervention_name>
    <description>cognitive training over 6 weeks, consist of 6 meetings (a 45minutes), three sessions focus on concentration tasks and three sessions on memory problems.</description>
    <arm_group_label>training</arm_group_label>
    <other_name>training group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>control group</intervention_name>
    <description>no intervention</description>
    <arm_group_label>control</arm_group_label>
    <other_name>controll group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with cancer 6 weeks after chemotherapy

        Exclusion Criteria:

          -  patients with neurological or psychiatric disorders

          -  patients without compliance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Niedeggen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Freie Universität Berlin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Susanne Effenberger, MSc</last_name>
    <phone>+49-30-8445-2410</phone>
    <email>susanne.effenberger@charite.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fernando Dimeo, MD</last_name>
    <phone>+49-30-8445-4834</phone>
    <email>fernando.dimeo@charite.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Charite Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>12200</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Susanne Effenberger, MSc</last_name>
      <phone>+49-30-8445-2410</phone>
      <email>susanne.effenberger@charite.de</email>
    </contact>
    <investigator>
      <last_name>susanne Effenberger, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 12, 2009</study_first_submitted>
  <study_first_submitted_qc>November 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2009</study_first_posted>
  <last_update_submitted>November 12, 2009</last_update_submitted>
  <last_update_submitted_qc>November 12, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 13, 2009</last_update_posted>
  <responsible_party>
    <name_title>Fernando Dimeo</name_title>
    <organization>Charite University, Berlin, Germany</organization>
  </responsible_party>
  <keyword>cognitive dysfunction chemotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

